Cost-minimization Analysis of Four Triple Therapies for Peptic Ulcer with Helicobacter Pylori Infection
- VernacularTitle:4种联合用药方案治疗幽门螺杆菌感染消化性溃疡的最小成本分析
- Author:
Daguo WANG
;
Ning YANG
- Publication Type:Journal Article
- Keywords:
Helicobacter pylori;
Peptic ulcer;
Therapeutic scheme;
Cost-minimization analysis
- From:
China Pharmacy
1991;0(05):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05),and the costs were 441.28,436.63,543.55 and 437.89 yuan respectively,showing no significant difference compared among Group A,B and D,but the cost in Group C was 20% higher than in other groups.CONCLUSION: Scheme C is recommended only when scheme A,B and D are invalid(such as the patients are allergic to Amoxicillin or Furazolidone or resistant to Metronidazole).
